S. Mythili Devi 1 , S. Satyavani 2 , N. Dinesh Kumar Reddy 3 , M. Nikhil 4
Colorectal cancer is the most common malignancy in the gastrointestinal tract. Worldwide, colorectal cancer shows large geographic differences, with a crude incidence of 6.5/7.7 cases per 100,000 females/males in less developed areas as opposed to 50.9/60.8 in more developed regions. Adenocarcinoma is the most common type of colorectal malignancy responsible for more than 90% of the cases. Recent technological advances in computed tomography (CT), ultrasound (US), and magnetic resonance imaging (MRI) have made the diagnosis easy and accurate. Although surgery is the mainstay of treatment, radiotherapy (RT) and chemotherapy (CT) play a vital role, particularly in locally advanced tumours. A prospective study of 72 patients of colorectal malignancy conducted during a period of 24 months JUNE 2013 – June2015 in GGH, and Kakinada
